A brain implant helps paralyzed patients type on a computer by decoding attempted finger movements. The device enables rapid, ...
Asking for help or giving instructions can feel intimidating, but being pushy helps ensure patients' well-being, says ...
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.
Amydis has received $2.5 million to continue mapping toxic deposits of TDP-43 in retinal tissue and develop an eye test for ...
Columnist Juliet Taylor reflects on the legacy of Leah Stavenhagen, who founded Her ALS Story for young women diagnosed with the disease.
Hearing how a family found meaning in the midst of their loss reminds columnist Kristin Neva that she isn't alone in her ...
Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing ...
Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results